BioCentury
ARTICLE | Company News

Management tracks: Astellas, Sanofi China, Zafgen

March 4, 2019 11:47 PM UTC

Astellas promoted James Kellerman to SVP and head of IP legal and Peter Sandor to SVP and primary focus lead for immuno-oncology. Kellerman was VP of IP, Americas region and Sandor was VP, head of oncology therapeutic area in marketing strategy. Astellas Pharma Inc. (Tokyo:4503) also hired Michael Rafa as SVP and head of IP innovation and new technologies. He was a partner at Haug Partners. The appointments are effective April 1.

Sanofi (Euronext:SAN; NASDAQ:SNY) appointed Pius Hornstein as general manager of the pharma's China and emerging markets global business unit, as well as the country chair of Sanofi China. He was the general manager and country chair of Sanofi Brazil. Hornstein succeeds Jean-Christophe Pointeau, who was promoted to the Europe region head of Sanofi's Genzyme Corp. unit...